Mana Capital Acquisition (MAAQ) Competitors $4.33 -0.43 (-9.03%) As of 05/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock MAAQ vs. GLSI, FTLF, LRMR, EDIT, EXOZ, ATOS, CGEN, NKTX, TARA, and ENTAShould you be buying Mana Capital Acquisition stock or one of its competitors? The main competitors of Mana Capital Acquisition include Greenwich LifeSciences (GLSI), FitLife Brands (FTLF), Larimar Therapeutics (LRMR), Editas Medicine (EDIT), Exozymes (EXOZ), Atossa Therapeutics (ATOS), Compugen (CGEN), Nkarta (NKTX), Protara Therapeutics (TARA), and Enanta Pharmaceuticals (ENTA). These companies are all part of the "pharmaceutical products" industry. Mana Capital Acquisition vs. Greenwich LifeSciences FitLife Brands Larimar Therapeutics Editas Medicine Exozymes Atossa Therapeutics Compugen Nkarta Protara Therapeutics Enanta Pharmaceuticals Mana Capital Acquisition (NASDAQ:MAAQ) and Greenwich LifeSciences (NASDAQ:GLSI) are both small-cap manufacturing companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, community ranking, valuation, earnings, risk and dividends. Do analysts prefer MAAQ or GLSI? Greenwich LifeSciences has a consensus price target of $39.00, indicating a potential upside of 297.96%. Given Greenwich LifeSciences' stronger consensus rating and higher probable upside, analysts plainly believe Greenwich LifeSciences is more favorable than Mana Capital Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mana Capital Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Greenwich LifeSciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer MAAQ or GLSI? Greenwich LifeSciences received 8 more outperform votes than Mana Capital Acquisition when rated by MarketBeat users. However, 100.00% of users gave Mana Capital Acquisition an outperform vote while only 47.37% of users gave Greenwich LifeSciences an outperform vote. CompanyUnderperformOutperformMana Capital AcquisitionOutperform Votes1100.00% Underperform VotesNo VotesGreenwich LifeSciencesOutperform Votes947.37% Underperform Votes1052.63% Is MAAQ or GLSI more profitable? Mana Capital Acquisition's return on equity of 0.00% beat Greenwich LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets Mana Capital AcquisitionN/A N/A N/A Greenwich LifeSciences N/A -185.12%-164.27% Does the media refer more to MAAQ or GLSI? In the previous week, Greenwich LifeSciences had 1 more articles in the media than Mana Capital Acquisition. MarketBeat recorded 1 mentions for Greenwich LifeSciences and 0 mentions for Mana Capital Acquisition. Mana Capital Acquisition's average media sentiment score of 0.00 beat Greenwich LifeSciences' score of -3.00 indicating that Mana Capital Acquisition is being referred to more favorably in the media. Company Overall Sentiment Mana Capital Acquisition Neutral Greenwich LifeSciences Very Negative Do insiders & institutionals have more ownership in MAAQ or GLSI? 68.4% of Mana Capital Acquisition shares are held by institutional investors. Comparatively, 4.2% of Greenwich LifeSciences shares are held by institutional investors. 51.7% of Greenwich LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, MAAQ or GLSI? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMana Capital AcquisitionN/AN/AN/AN/AN/AGreenwich LifeSciencesN/AN/A-$8.89M-$1.20-8.17 SummaryGreenwich LifeSciences beats Mana Capital Acquisition on 6 of the 11 factors compared between the two stocks. Get Mana Capital Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for MAAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAAQ vs. The Competition Export to ExcelMetricMana Capital AcquisitionIn Vitro, In Vivo Diagnostic Substances IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$35.18M$35.18M$2.04B$8.39BDividend YieldN/AN/A2.64%4.11%P/E RatioN/AN/A22.9219.71Price / SalesN/AN/A60.71120.53Price / CashN/AN/A51.7234.62Price / BookN/AN/A2.064.50Net IncomeN/AN/A-$292.00M$248.22M7 Day Performance8.25%8.25%-0.39%-0.78%1 Month Performance1,010.54%1,010.54%8.96%11.53%1 Year Performance518.57%518.57%13.38%8.99% Mana Capital Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAAQMana Capital AcquisitionN/A$4.33-9.0%N/A+518.6%$35.18MN/A0.001GLSIGreenwich LifeSciences1.1735 of 5 stars$9.74+0.5%$39.00+300.4%-27.4%$129.29MN/A-12.173Positive NewsEarnings ReportFTLFFitLife Brands4.4196 of 5 stars$13.64-5.7%$20.50+50.3%+0.0%$128.00M$64.47M16.1420Analyst DowngradeGap UpLRMRLarimar Therapeutics2.0541 of 5 stars$1.98+5.9%$19.63+891.2%-75.6%$126.78MN/A-1.7230Positive NewsEDITEditas Medicine4.2866 of 5 stars$1.51+8.2%$5.36+255.2%-73.1%$126.40M$32.31M-0.59230EXOZExozymesN/A$15.04+10.9%N/AN/A$125.86MN/A0.0029Gap UpATOSAtossa Therapeutics2.0187 of 5 stars$0.97-1.6%$7.13+634.5%-43.1%$125.31MN/A-4.418CGENCompugen1.7576 of 5 stars$1.39+1.5%$4.00+187.8%-37.2%$124.04M$27.86M69.5070News CoverageEarnings ReportAnalyst RevisionNKTXNkarta1.9389 of 5 stars$1.74+1.2%$14.67+742.9%-74.6%$123.47MN/A-0.93140TARAProtara Therapeutics2.9167 of 5 stars$3.19+2.6%$20.40+539.5%+6.0%$123.08MN/A-1.1330Positive NewsAnalyst ForecastGap UpENTAEnanta Pharmaceuticals3.8211 of 5 stars$5.75+7.1%$17.25+200.0%-55.1%$122.67M$66.59M-1.16160Positive News Related Companies and Tools Related Companies GLSI Alternatives FTLF Alternatives LRMR Alternatives EDIT Alternatives EXOZ Alternatives ATOS Alternatives CGEN Alternatives NKTX Alternatives TARA Alternatives ENTA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MAAQ) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mana Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mana Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
